JPS6354710B2 - - Google Patents

Info

Publication number
JPS6354710B2
JPS6354710B2 JP53100824A JP10082478A JPS6354710B2 JP S6354710 B2 JPS6354710 B2 JP S6354710B2 JP 53100824 A JP53100824 A JP 53100824A JP 10082478 A JP10082478 A JP 10082478A JP S6354710 B2 JPS6354710 B2 JP S6354710B2
Authority
JP
Japan
Prior art keywords
group
general formula
carbon atoms
formula
represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP53100824A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5441871A (en
Inventor
Dosuteru Fuiritsupu
Dozon Koretsuto
Buurugerii Gii
Guure Kuroodo
Motsukyuu Gizeeru
Kosuton Jannaran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Delalande SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7726105A external-priority patent/FR2381037A2/fr
Priority claimed from FR7815342A external-priority patent/FR2426684A2/fr
Application filed by Delalande SA filed Critical Delalande SA
Publication of JPS5441871A publication Critical patent/JPS5441871A/ja
Publication of JPS6354710B2 publication Critical patent/JPS6354710B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP10082478A 1977-08-26 1978-08-18 Novel 55hydroxymethyloxazolidinons and its manufacture Granted JPS5441871A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7726105A FR2381037A2 (fr) 1977-02-22 1977-08-26 Nouvelles hydroxymethyl-5 oxazolidinones-2, leur procede de preparation et leur application therapeutique
FR7815342A FR2426684A2 (fr) 1978-05-23 1978-05-23 Nouvelles hydroxymethyl-5 oxazolidinones-2, leur procede de preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
JPS5441871A JPS5441871A (en) 1979-04-03
JPS6354710B2 true JPS6354710B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-10-28

Family

ID=26220188

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10082478A Granted JPS5441871A (en) 1977-08-26 1978-08-18 Novel 55hydroxymethyloxazolidinons and its manufacture

Country Status (13)

Country Link
US (2) US4250318A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5441871A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU526714B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1113093A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH634836A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2836305A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES472825A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2003151B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR64146B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1118099B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU80081A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7808817A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE444813B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1087643A (ja) * 1996-05-03 1998-04-07 Ciba Specialty Chem Holding Inc 環状アミンにより置換されたフェニルアルキルケトンおよび該化合物の製造方法
CN103601724A (zh) * 2013-11-14 2014-02-26 暨南大学 一种新型噁唑烷酮类化合物及其制备方法和应用

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53108278A (en) * 1977-11-14 1978-09-20 Nec Corp Manufacture of semiconductor device
US4348393A (en) 1978-06-09 1982-09-07 Delalande S.A. N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones
FR2460940A2 (fr) * 1979-07-10 1981-01-30 Delalande Sa Nouvelles hydroxymethyl-5 oxazolidinones-2, leur procede de preparation et leur application en therapeutique
CA1171865A (en) * 1980-06-04 1984-07-31 Alain Lacour N-aryl azolone derivatives, the process for preparing the same and their application in therapeutics
US4340606A (en) * 1980-10-23 1982-07-20 E. I. Du Pont De Nemours And Company 3-(p-Alkylsulfonylphenyl)oxazolidinone derivatives as antibacterial agents
JPS57128058A (en) * 1980-12-15 1982-08-09 Seiko Epson Corp Manufacture of semiconductor device
FR2500450A1 (fr) * 1981-02-25 1982-08-27 Delalande Sa Nouveaux derives aminomethyl-5 oxazolidiniques, leur procede de preparation et leur application en therapeutique
AU560666B2 (en) * 1981-12-04 1987-04-16 E.I. Du Pont De Nemours And Company P(2-oxo oxazolidinyl)benzene sulphonamides
US4405794A (en) * 1981-12-18 1983-09-20 The Dow Chemical Company Preparation of 2-oxazolidinone and ethyleneurea
FR2528046B1 (fr) * 1982-06-08 1985-06-21 Delalande Sa Derives de l'oxazolidinone-2 n-arylee optiquement actifs, inhibiteurs specifiques et reversibles de la monoamine oxydase de type b et leur procede de preparation
US4461773A (en) * 1982-09-15 1984-07-24 E. I. Dupont De Nemours And Company P-Oxooxazolidinylbenzene compounds as antibacterial agents
US4500717A (en) * 1983-03-28 1985-02-19 The Dow Chemical Company Process for preparation of 2-oxazolidinones
US4705799A (en) * 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
US4732956A (en) * 1984-06-18 1988-03-22 Loctite (Ireland) Ltd. Styryloxy resins and compositions thereof
CA1260948A (en) 1984-12-05 1989-09-26 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzene derivatives useful as antibacterial agents
US5032605A (en) * 1987-10-09 1991-07-16 Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl oxa or thia cycloalkylbenzene derivatives useful as antibacterial agents
US4921869A (en) * 1987-10-09 1990-05-01 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4965268A (en) * 1987-10-09 1990-10-23 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US5036093A (en) * 1987-10-09 1991-07-30 Du Pont Merck Pharmaceutical Aminomethyl oxooxazolidinyl azacycloalkylbenzene derivatives useful as antibacterial agents
US4985429A (en) * 1987-10-09 1991-01-15 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US5039690A (en) * 1987-10-09 1991-08-13 Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl oxa or thia cycloalkylbenzene derivatives useful as antibacterial agents
US5036092A (en) * 1987-10-09 1991-07-30 Du Pont Merck Pharmaceutical Aminomethyl oxooxazolidinyl azacycloalkylbenzene derivatives useful as antibacterial agents
US4942183A (en) * 1987-10-16 1990-07-17 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
US4977173A (en) * 1987-10-21 1990-12-11 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl ethenylbenzene derivatives useful as antibacterial agents
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5225565A (en) * 1988-09-15 1993-07-06 The Upjohn Company Antibacterial 3-(fused-ring substituted)phenyl-5β-amidomethyloxazolidin-2-ones
US5182403A (en) * 1988-09-15 1993-01-26 The Upjohn Company Substituted 3(5'indazolyl) oxazolidin-2-ones
FR2653017B1 (fr) * 1989-10-17 1995-05-05 Delalande Sa Derives d'aryl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique.
US5196543A (en) * 1989-10-17 1993-03-23 Delalande S.A. 3-aryloxazolidinone derivatives, process for their preparation and their use in therapy
US5235063A (en) * 1989-10-17 1993-08-10 Delalande S.A. Process of preparing by condensation certain
US5231188A (en) * 1989-11-17 1993-07-27 The Upjohn Company Tricyclic [6.5.51]-fused oxazolidinone antibacterial agents
JP2841976B2 (ja) * 1990-11-28 1998-12-24 日本電気株式会社 半導体装置およびその製造方法
AU667198B2 (en) * 1991-11-01 1996-03-14 Pharmacia & Upjohn Company Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
EP0673370B1 (en) * 1992-12-08 1998-01-07 PHARMACIA & UPJOHN COMPANY Tropone-substituted phenyloxazolidinone antibacterial agents
TW286317B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1993-12-13 1996-09-21 Hoffmann La Roche
US5883093A (en) * 1995-09-12 1999-03-16 Pharmacia & Upjohn Company Phenyloxazolidinone antimicrobials
FR2741071B1 (fr) * 1995-11-09 1997-12-12 Synthelabo Derives de 3-(benzofuran-5-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique
CN1082953C (zh) * 1996-04-11 2002-04-17 法玛西雅厄普约翰美国公司 制备噁唑烷酮的方法
US6037354A (en) 1997-06-18 2000-03-14 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
KR100619639B1 (ko) 1997-11-07 2006-09-06 파마시아 앤드 업존 캄파니 엘엘씨 옥사졸리디논의 제조 방법
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
ATE321024T1 (de) * 2000-10-17 2006-04-15 Pharmacia & Upjohn Co Llc Verfahren zur herstellung von oxazolidinonverbindungen
DE10129725A1 (de) * 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
TW200302095A (en) * 2002-01-25 2003-08-01 Upjohn Co Oxazolidinone cotherapy
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) * 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE502006009169D1 (en) 2005-10-04 2011-05-05 Bayer Schering Pharma Ag NEUE POLYMORPHE FORM VON 5-CHLOR-N-(ä ( 5S )-2-0X0-3-Ä4-( 3-OXO-4-MORPHOLINYL)-PHENYLÜ-1,3-OXAZOLIDIN-5-YLü -METHYL)-2-THIOPHENCARBOXAMID
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DE102005048824A1 (de) * 2005-10-10 2007-04-12 Bayer Healthcare Ag Behandlung und Prophylaxe von Mikroangiopathien
DE102006051625A1 (de) * 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
RU2556234C2 (ru) * 2008-10-10 2015-07-10 Траюс Терапьютикс Способы получения оксазолидинонов и содержащих их композиций
JP5584705B2 (ja) 2009-02-03 2014-09-03 トリウス セラピューティクス Ｒ）−３−（４−（２−（２−メチルテトラゾール−５−イル）ピリジン−５−イル）−３−フルオロフェニル）−５−ヒドロキシメチルオキサゾリジン−２−オンリン酸二水素の結晶形
US8580767B2 (en) * 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use
CN103965085B (zh) * 2014-04-17 2016-02-24 上海恒晟药业有限公司 一种取代1,2-氨基醇药物的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1180089A (en) * 1967-10-20 1970-02-04 Delalande Sa Acetylenic Derivatives of 2-Oxazolidinones and processes of preparation
GB1224995A (en) * 1968-09-20 1971-03-10 Delalande Sa New 5-propargyloxymethyl-2-substituted oxazolidinones and their process of preparation
GB1222708A (en) * 1968-10-22 1971-02-17 Delalande Sa Novel 5-(n-substituted aminomethyl)-2-oxazolidinones and their process of preparation
GB1250538A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1969-03-18 1971-10-20
DE2538424C2 (de) * 1975-08-29 1983-01-05 Nordmark-Werke Gmbh, 2000 Hamburg 4-substituierte 5-Phenyl-oxazolidon-(2)- Verbindungen und ein diese enthaltendes pharmazeutisches Präparat
FR2356422A1 (fr) * 1976-03-01 1978-01-27 Delalande Sa Nouveaux hydroxymethyl-5 oxazolidinone-2, leur procede de preparation et leur application en therapeutique
JPS6040428A (ja) * 1983-08-12 1985-03-02 Wakachiku Kensetsu Kk ケ−ソンの据付工法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1087643A (ja) * 1996-05-03 1998-04-07 Ciba Specialty Chem Holding Inc 環状アミンにより置換されたフェニルアルキルケトンおよび該化合物の製造方法
CN103601724A (zh) * 2013-11-14 2014-02-26 暨南大学 一种新型噁唑烷酮类化合物及其制备方法和应用

Also Published As

Publication number Publication date
GB2003151A (en) 1979-03-07
SE444813B (sv) 1986-05-12
CA1113093A (fr) 1981-11-24
GB2003151B (en) 1982-10-06
SE7808804L (sv) 1979-02-27
GR64146B (en) 1980-01-31
NL7808817A (nl) 1979-02-28
IT7868979A0 (it) 1978-08-25
IT1118099B (it) 1986-02-24
DE2836305A1 (de) 1979-03-01
CH634836A5 (fr) 1983-02-28
JPS5441871A (en) 1979-04-03
US4338451A (en) 1982-07-06
US4250318A (en) 1981-02-10
AU526714B2 (en) 1983-01-27
LU80081A1 (fr) 1979-05-15
AU3924978A (en) 1980-02-28
ES472825A1 (es) 1979-02-16

Similar Documents

Publication Publication Date Title
JPS6354710B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
US4657911A (en) 3-amino quinuclidine derivatives and the application thereof as accelerators of gastro-intestinal motor function
EP1572671A1 (de) Nichtsteroidale entzündungshemmer
JPS5838273A (ja) 新規な５−アミノメチルオキサゾリジン誘導体及びその製造法並びにこれを含有する薬剤
WO2000064884A1 (en) Piperidyl-imidazole derivatives, their preparations and therapeutic uses
US3637660A (en) Dibenzazepine derivatives
JPH07504919A (ja) ５−ｈｔ１作動薬としてのインドール誘導体
JPS5890567A (ja) ヘテロ環式化合物、その製法および該化合物を含有する、強心および／または抗高血圧作用を有する製薬組成物
JPS6040428B2 (ja) 新規３−アリ−ル−２−オキサゾリジノン誘導体、その製法及び該誘導体を含有する抗抑うつ剤
JPS59106491A (ja) ベンゾキサジン化合物
JPS5919549B2 (ja) 異節環状化合物
JPH0367071B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP0089028A1 (de) Neue Theophyllin-Derivate und Verfahren zu ihrer Herstellung
FI62074C (fi) Foerfarande foer framstaellning av nya farmakologiskt aktiva 5-fenyl-oxazolidinon-2-foereningar
JPS6330911B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS6360985A (ja) ４，７−ジヒドロピラゾロ〔１，５−ａ〕ピリミジン誘導体
EP0077720A1 (fr) Dérivés de biphényl alcoyl carboxylates, leur procédé de préparation et leur utilisation comme médicaments
TW204347B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS6245864B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPH01203361A (ja) 新規の３―ピぺリジンカルバルデヒドのオキシムの誘導体、それらの製造方法及びそれらの薬剤としての使用
US4173636A (en) Decahydroquinolines, pharmaceutical compositions and methods of use
US4287211A (en) Derivatives of phenylethylamines, processes for their preparation and related pharmaceutical compositions
FR2636065A1 (fr) Nouveaux derives de dihydro-2,3 arylacoylaminoalcoyl-3 4h-benzoxazine-1,3 ones-4, leur preparation et leur application en tant que medicaments utiles en therapeutique
FR2605008A1 (fr) Derives d'imidazo (4,5-b)pyridinone-2, leur preparation et leur application en therapeutique
US3170933A (en) 2-(gamma-methoxypropyl-aminomethyl)-1, 4-benzodioxane